The administration's FDA reforms and reduced biopharmaceutical drug prices / / The Council of Economic Advisers |
Pubbl/distr/stampa | [Washington, D.C.] : , : Executive Office of the President of the United States, Council of Economic Advisers, , 2018 |
Descrizione fisica | 1 online resource (17 pages) : color illustrations |
Soggetto topico |
Drugs - United States - Costs
Drug approval - United States Generic drugs - Government policy - United States Drug development - United States Pharmaceutical industry - Deregulation - United States Competition - Government policy - United States |
Formato | Materiale a stampa |
Livello bibliografico | Monografia |
Lingua di pubblicazione | eng |
Altri titoli varianti | Administration's Food and Drug Administration reforms and reduced biopharmaceutical drug prices |
Record Nr. | UNINA-9910711563903321 |
[Washington, D.C.] : , : Executive Office of the President of the United States, Council of Economic Advisers, , 2018 | ||
Materiale a stampa | ||
Lo trovi qui: Univ. Federico II | ||
|
Developments in the prescription drug market : oversight : hearing before the Committee on Oversight and Government Reform, House of Representatives, One Hundred Fourteenth Congress, second session, February 4, 2016 |
Pubbl/distr/stampa | Washington : , : U.S. Government Publishing Office, , 2017 |
Descrizione fisica | 1 online resource (iii, 213 pages) : illustrations |
Soggetto topico |
Prescription pricing - United States
Pharmaceutical industry - Corrupt practices - United States Generic drugs - Government policy - United States Drug approval - United States |
Soggetto genere / forma | Legislative hearings. |
Formato | Materiale a stampa |
Livello bibliografico | Monografia |
Lingua di pubblicazione | eng |
Altri titoli varianti | Developments in the prescription drug market |
Record Nr. | UNINA-9910705706003321 |
Washington : , : U.S. Government Publishing Office, , 2017 | ||
Materiale a stampa | ||
Lo trovi qui: Univ. Federico II | ||
|
The Food and Drug Administration's generic drug review process |
Pubbl/distr/stampa | [Washington, D.C.] : , : Department of Health and Human Services, Office of Inspector General, , 2008 |
Descrizione fisica | 1 online resource (iii, 36 pages) : illustrations |
Soggetto topico |
Generic drugs - Government policy - United States
Drugs - United States - Testing |
Formato | Materiale a stampa |
Livello bibliografico | Monografia |
Lingua di pubblicazione | eng |
Altri titoli varianti | Food and Drug Administration's generic drug review process |
Record Nr. | UNINA-9910707485903321 |
[Washington, D.C.] : , : Department of Health and Human Services, Office of Inspector General, , 2008 | ||
Materiale a stampa | ||
Lo trovi qui: Univ. Federico II | ||
|
Full committee hearing on Medicaid drug reimbursements : are CMS cuts bad medicine for small businesses and beneficiaries? / / Committee on Small Business, United States House of Representatives |
Descrizione fisica | 1 online resource (v, 77 p.) |
Soggetto topico |
Drugs - Prices - United States
Pharmaceutical services insurance - United States Generic drugs - Government policy - United States |
Soggetto non controllato |
Drugs
Generic drugs Law Medical |
Formato | Materiale a stampa |
Livello bibliografico | Monografia |
Lingua di pubblicazione | eng |
Altri titoli varianti | Full committee hearing on Medicaid drug reimbursements |
Record Nr. | UNINA-9910694498203321 |
Materiale a stampa | ||
Lo trovi qui: Univ. Federico II | ||
|
Review of the proposed generic drug and biosimilars user fees and further examination of drug shortages : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Twelfth Congress, second session, February 9, 2012 |
Pubbl/distr/stampa | Washington : , : U.S. Government Printing Office, , 2013 |
Descrizione fisica | 1 online resource (iv, 194 pages) : illustrations |
Soggetto topico |
Drug approval - United States
Generic drugs - Government policy - United States Biologicals - Government policy - United States Drug accessibility - United States Fees, Administrative - United States |
Formato | Materiale a stampa |
Livello bibliografico | Monografia |
Lingua di pubblicazione | eng |
Altri titoli varianti | Review of the proposed generic drug and biosimilars user fees and further examination of drug shortages |
Record Nr. | UNINA-9910704729003321 |
Washington : , : U.S. Government Printing Office, , 2013 | ||
Materiale a stampa | ||
Lo trovi qui: Univ. Federico II | ||
|
Staff report on Sanofi's strategic use of third parties to influence the FDA [[electronic resource] /] / prepared by the staff of the Committee on Finance, United States Senate |
Pubbl/distr/stampa | Washington : , : U.S. G.P.O., , 2011 |
Descrizione fisica | 1 online resource (iii, 177 pages) |
Collana | S. prt. |
Soggetto topico |
Drug approval - Corrupt practices - United States
Anticoagulants (Medicine) - Government policy - United States Generic drugs - Government policy - United States |
Formato | Materiale a stampa |
Livello bibliografico | Monografia |
Lingua di pubblicazione | eng |
Record Nr. | UNINA-9910700723503321 |
Washington : , : U.S. G.P.O., , 2011 | ||
Materiale a stampa | ||
Lo trovi qui: Univ. Federico II | ||
|